Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazila Jamshidi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
BMC Medical Imaging|January 19, 2020
Methadone-induced encephalopathy: a case series and literature reviewMaryam Haghighi-Morad, Zahra Naseri, Nazila Jamshidi, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 19, 2023
N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trialKirsten C Morley, Siena Peruch, Claire Adams, et al.
Frontiers in Psychiatry|December 8, 2018
Baclofen Response in Alcohol Dependent Patients Concurrently Receiving Antidepressants: Secondary Analysis From the BacALD StudySovandara Heng, Nazila Jamshidi, Andrew Baillie, et al.
The International Journal on Drug Policy|September 30, 2023
Has there been an increase in nitrous oxide use and associated harms in Australia? An analysis of triangulated data sources, 2003-2020Rachel Sutherland, Nicola Man, Jared Brown, et al.
British Journal of Clinical Pharmacology|March 19, 2022
Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testingNazila Jamshidi, Akshay Athavale, Christopher Tremonti, et al.
Journal of Cannabis Research|August 16, 2025
Clinicians' attitudes and knowledge of medicinal cannabis in opioid dependence treatment clinics in New South Wales, AustraliaLaila Parvaresh, Llewellyn Mills, Jaleh Gholami, et al.
Drug and Alcohol Review|May 6, 2025
Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence TreatmentLaila Parvaresh, Llewellyn Mills, Jaleh Gholami, et al.
Emergency Medicine Australasia : EMA|April 1, 2024
Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021Oliver Harris, Krista J Siefried, Angela Chiew, et al.
Journal of Addiction Medicine|December 3, 2024
Methadone-Buprenorphine Transfers Using Low Dosing of Buprenorphine: An Open-label, Nonrandomized Clinical TrialChris Tremonti, James Blogg, Nazila Jamshidi, et al.
The American Journal of Psychiatry|May 6, 2024
Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled TrialKirsten C Morley, Henry R Kranzler, Natasha Luquin, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMC Medical Imaging|January 19, 2020
Methadone-induced encephalopathy: a case series and literature reviewMaryam Haghighi-Morad, Zahra Naseri, Nazila Jamshidi, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|July 19, 2023
N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trialKirsten C Morley, Siena Peruch, Claire Adams, et al.
Frontiers in Psychiatry|December 8, 2018
Baclofen Response in Alcohol Dependent Patients Concurrently Receiving Antidepressants: Secondary Analysis From the BacALD StudySovandara Heng, Nazila Jamshidi, Andrew Baillie, et al.
The International Journal on Drug Policy|September 30, 2023
Has there been an increase in nitrous oxide use and associated harms in Australia? An analysis of triangulated data sources, 2003-2020Rachel Sutherland, Nicola Man, Jared Brown, et al.
British Journal of Clinical Pharmacology|March 19, 2022
Evaluation of adherence monitoring in buprenorphine treatment: A pilot study using timed drug assays to determine accuracy of testingNazila Jamshidi, Akshay Athavale, Christopher Tremonti, et al.
Journal of Cannabis Research|August 16, 2025
Clinicians' attitudes and knowledge of medicinal cannabis in opioid dependence treatment clinics in New South Wales, AustraliaLaila Parvaresh, Llewellyn Mills, Jaleh Gholami, et al.
Drug and Alcohol Review|May 6, 2025
Clinicians' Perspectives on Cannabis Use and Cannabis Treatment in Clients Undertaking Opioid Dependence TreatmentLaila Parvaresh, Llewellyn Mills, Jaleh Gholami, et al.
Emergency Medicine Australasia : EMA|April 1, 2024
Trends in reported GHB-related presentations to Sydney emergency departments between 2012 and 2021Oliver Harris, Krista J Siefried, Angela Chiew, et al.
Journal of Addiction Medicine|December 3, 2024
Methadone-Buprenorphine Transfers Using Low Dosing of Buprenorphine: An Open-label, Nonrandomized Clinical TrialChris Tremonti, James Blogg, Nazila Jamshidi, et al.
The American Journal of Psychiatry|May 6, 2024
Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled TrialKirsten C Morley, Henry R Kranzler, Natasha Luquin, et al.
Pageof 3